Research Article

Predictive Value of Novel Inflammation-Based Biomarkers for Pulmonary Hypertension in the Acute Exacerbation of Chronic Obstructive Pulmonary Disease

Table 5

Univariate and multivariate analysis of the effects of the baseline parameters on PH.

FactorsUnivariate analysisMultivariate analysis
OR (95% CI) valueOR (95% CI) value

Lymphocyte (109/l)0.226 (0.114, 0.448)<0.0011.055 (0.273, 4.078)0.938
NLR1.173 (1.081, 1.273)<0.0011.161 (0.924, 1.458)0.200
PLR1.006 (1.003, 1.009)<0.0011.003 (0.993, 1.013)0.564
SII1.001 (1.000, 1.001)<0.0010.999 (0.998, 1.001)0.256
NT-proBNP (pg/ml)1.003 (1.001, 1.004)<0.0011.002 (1.001, 1.003)<0.001
PaCO2 (mmHg)1.047 (1.019, 1.075)<0.0011.018 (0.939, 1.104)0.664
HCO3- (mmol/l)1.103 (1.042, 1.167)<0.0010.981 (0.822, 1.170)0.828
Lac (mmol/l)1.911 (1.130, 3.234)0.0161.663 (0.837, 3.305)0.146
D-Dimer (μg/ml)1.910 (1.235, 2.953)0.00361.581 (0.960, 2.603)0.072

Abbreviations: PH—pulmonary hypertension; PaCO2—partial pressure of carbon dioxide; HCO3-—bicarbonate ion; NLR—neutrophil-to-lymphocyte ratio; PLR—platelet-to-lymphocyte ratio; SII—systemic-immune-inflammation index; Lac—lactic acid; CI—confidence intervals; OR—odds ratio.